On the public citation graph
Cell‐Surface labeling and internalization by a fluorescent inhibitor of prostate‐specific membrane antigen
0 signed · 129 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cmdc.200500044openalex-snapshot
Design and Synthesis of a PSMA Inhibitor–Doxorubicin Conjugate for Targeted Prostate Cancer Therapy
inferredcites →https://doi.org/10.1002/pros.10117openalex-snapshot
Anti‐tumor effects of toxins targeted to the prostate specific membrane antigen
inferredcites →https://doi.org/10.1007/s003350010240openalex-snapshot
Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase
inferredcites →https://doi.org/10.1016/j.bios.2005.12.015openalex-snapshot
Labeling tumor cells with fluorescent nanocrystal–aptamer bioconjugates
inferredcites →https://doi.org/10.1016/j.bmc.2004.06.031openalex-snapshot
Probing for a hydrophobic a binding register in prostate-specific membrane antigen with phenylalkylphosphonamidates
inferredcites →https://doi.org/10.1016/j.bmc.2005.07.056openalex-snapshot
Optimizing phenylethylphosphonamidates for the inhibition of prostate-specific membrane antigen
inferredcites →https://doi.org/10.1016/j.bmc.2007.07.028openalex-snapshot
The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen
inferredcites →https://doi.org/10.1016/j.bmc.2007.08.006openalex-snapshot
Substrate specificity of prostate-specific membrane antigen
inferredcites →https://doi.org/10.1016/j.bmcl.2007.10.096openalex-snapshot
Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen
inferredcites →https://doi.org/10.1016/j.drudis.2007.07.010openalex-snapshot
Progress in the discovery and development of glutamate carboxypeptidase II inhibitors
inferredcites →https://doi.org/10.1016/j.neulet.2005.06.015openalex-snapshot
Glutamate carboxypeptidase II levels in rodent brain using [125I]DCIT quantitative autoradiography
inferredcites →https://doi.org/10.1016/j.pep.2006.05.008openalex-snapshot
Purification of prostate-specific membrane antigen using conformational epitope-specific antibody-affinity chromatography
inferredcites →https://doi.org/10.1016/j.urology.2005.03.043openalex-snapshot
Future therapies in hormone-refractory prostate cancer
inferredcites →https://doi.org/10.1016/s0006-291x(03)01119-7openalex-snapshot
Prostate targeting ligands based on N-acetylated α-linked acidic dipeptidase
inferredcites →https://doi.org/10.1016/s0021-9258(18)32120-3openalex-snapshot
Internalization and subcellular localization of transferrin and transferrin receptors in HeLa cells.
inferredcites →https://doi.org/10.1016/s0021-9258(18)32481-5openalex-snapshot
Receptor-mediated endocytosis of transferrin in K562 cells.
inferredcites →https://doi.org/10.1016/s0021-9258(18)47823-4openalex-snapshot
Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain.
inferredcites →https://doi.org/10.1016/s0090-4295(01)00983-9openalex-snapshot
Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma
inferredcites →https://doi.org/10.1016/s0960-894x(03)00407-4openalex-snapshot
Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II
inferredcites →https://doi.org/10.1016/s0968-0896(03)00427-9openalex-snapshot
Conformational and SAR analysis of NAALADase and PSMA inhibitors
inferredcites →https://doi.org/10.1016/s1078-1439(03)00151-0openalex-snapshot
Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor
inferredcites →https://doi.org/10.1021/ac050312qopenalex-snapshot
Microfluidic System for Studying the Interaction of Nanoparticles and Microparticles with Cells
inferredcites →https://doi.org/10.1021/jm020515wopenalex-snapshot
Synthesis and Biological Evaluation of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II: Discovery of an Orally Active GCP II Inhibitor
inferredcites →https://doi.org/10.1021/jm0306226openalex-snapshot
Synthesis of Urea-Based Inhibitors as Active Site Probes of Glutamate Carboxypeptidase II: Efficacy as Analgesic Agents
inferredcites →https://doi.org/10.1021/jm051019lopenalex-snapshot
Structural Optimization of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II by Modification of the P1‘ Side Chain
inferredcites →https://doi.org/10.1021/jm950801qopenalex-snapshot
Design, Synthesis, and Biological Activity of a Potent Inhibitor of the Neuropeptidase N-Acetylated α-Linked Acidic Dipeptidase
inferredcites →https://doi.org/10.1038/nbt994openalex-snapshot
In vivo cancer targeting and imaging with semiconductor quantum dots
inferredcites →https://doi.org/10.1038/nrd1903openalex-snapshot
NAAG peptidase inhibitors and their potential for diagnosis and therapy
inferredcites →https://doi.org/10.1038/sj.emboj.7600969openalex-snapshot
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
inferredcites →https://doi.org/10.1039/b615603gopenalex-snapshot
Design, synthesis and pharmacological activity of novel enantiomerically pure phosphonic acid-based NAALADase inhibitors
inferredcites →https://doi.org/10.1046/j.0022-3042.2001.00715.xopenalex-snapshot
Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II
inferredcites →https://doi.org/10.1073/pnas.0502101102openalex-snapshot
Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase
inferredcites →https://doi.org/10.1073/pnas.79.20.6186openalex-snapshot
Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment.
inferredcites →https://doi.org/10.1073/pnas.80.8.2258openalex-snapshot
pH and the recycling of transferrin during receptor-mediated endocytosis.
inferredcites →https://doi.org/10.1073/pnas.81.10.3005openalex-snapshot
Rapid internalization of the transferrin receptor in K562 cells is triggered by ligand binding or treatment with a phorbol ester.
inferredcites →https://doi.org/10.1083/jcb.128.4.549openalex-snapshot
Evidence for nonvectorial, retrograde transferrin trafficking in the early endosomes of HEp2 cells.
inferredcites →https://doi.org/10.1083/jcb.97.2.508openalex-snapshot
Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells.
inferredcites →https://doi.org/10.1084/jem.187.10.1583openalex-snapshot
Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy
inferredcites →https://doi.org/10.1089/02724570050109648openalex-snapshot
Isolation and Characterization of Monoclonal Antibodies Specific for Protein Conformational Epitopes Present in Prostate-Specific Membrane Antigen (PSMA)
inferredcites →https://doi.org/10.1091/mbc.e02-11-0731openalex-snapshot
A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen
inferredcites →https://doi.org/10.1111/j.1471-4159.1990.tb08818.xopenalex-snapshot
Competitive Inhibition of N‐Acetylated‐α‐Linked Acidic Dipeptidase Activity by N‐Acetyl‐L‐Aspartyl‐β‐Linked L‐Glutamate
inferredcites →https://doi.org/10.1124/jpet.106.117648openalex-snapshot
Characterization of the pH of Folate Receptor-Containing Endosomes and the Rate of Hydrolysis of Internalized Acid-Labile Folate-Drug Conjugates
inferredcites →https://doi.org/10.1158/0008-5472.can-06-1520openalex-snapshot
A Dimeric Peptide That Binds Selectively to Prostate-Specific Membrane Antigen and Inhibits its Enzymatic Activity
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-2690openalex-snapshot
Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen:In vivoImaging in Experimental Models of Prostate Cancer
inferredcites →https://doi.org/10.1162/153535002320162750openalex-snapshot
11C-MCG: Synthesis, Uptake Selectivity, and Primate PET of a Probe for Glutamate Carboxypeptidase II (NAALADase)
inferredcites →https://doi.org/10.1200/jco.2005.05.160openalex-snapshot
Phase I Trial of 177 Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer
inferredcites →https://doi.org/10.1200/jco.2006.07.8097openalex-snapshot
Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors
inferredcites →https://doi.org/10.1615/critrevimmunol.v21.i1-3.160openalex-snapshot
A Unique Folate Hydrolase, Prostate-Specific Membrane Antigen (PSMA): A Target For Immunotherapy?
inferredcites →https://doi.org/10.2310/7290.2005.05163openalex-snapshot
High-affinity Near-infrared Fluorescent Small-molecule Contrast Agents for In Vivo Imaging of Prostate-specific Membrane Antigen
inferredcites →https://doi.org/10.2741/salitopenalex-snapshot
Ins and outs of clinical trials with peptide-based vaccines
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9780470508169.ch36openalex-snapshot
Recent Development of Diagnostic and Therapeutic Agents Targeting Glutamate Carboxypeptidase II (GCPII)
inferred← citeshttps://doi.org/10.1002/cmdc.70406openalex-snapshot
Design, Synthesis, and In Vitro Evaluation of a PSMA‐Targeted Doxorubicin Conjugate
inferred← citeshttps://doi.org/10.1002/cnr2.1169openalex-snapshot
Comparison of prostate‐specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer
inferred← citeshttps://doi.org/10.1002/elps.200900141openalex-snapshot
Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate‐specific membrane antigen aptamers immobilized to a polymeric microfluidic device
inferred← citeshttps://doi.org/10.1002/lsm.21101openalex-snapshot
Liposomal nanostructures for photosensitizer delivery
inferred← citeshttps://doi.org/10.1002/pros.20909openalex-snapshot
In vitro targeted photodynamic therapy with a pyropheophorbide‐a conjugated inhibitor of prostate‐specific membrane antigen
inferred← citeshttps://doi.org/10.1002/pros.21221openalex-snapshot
Flow cytometric detection of prostate tumor cells using chemoaffinity labels
inferred← citeshttps://doi.org/10.1002/pros.21493openalex-snapshot
A phosphoramidate‐based prostate‐specific membrane antigen‐targeted SPECT agent
inferred← citeshttps://doi.org/10.1002/pros.22508openalex-snapshot
Chemoaffinity capture of pre‐targeted prostate cancer cells with magnetic beads
inferred← citeshttps://doi.org/10.1002/pros.22575openalex-snapshot
PSMA‐targeted SPECT agents: Mode of binding effect on in vitro performance
inferred← citeshttps://doi.org/10.1002/pros.22727openalex-snapshot
Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells
inferred← citeshttps://doi.org/10.1002/pros.23642openalex-snapshot
Meeting report from the Prostate Cancer Foundation PSMA‐directed radionuclide scientific working group
inferred← citeshttps://doi.org/10.1007/128_2014_562openalex-snapshot
Recent Advances in H-Phosphonate Chemistry. Part 1. H-Phosphonate Esters: Synthesis and Basic Reactions
inferred← citeshttps://doi.org/10.1007/7355_2019_86openalex-snapshot
Fluorescence Molecular Imaging of Medicinal Chemistry in Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-00796-4_14openalex-snapshot
Recent Advancements in Prodrug Strategies for Targeted Cancer Therapy
inferred← citeshttps://doi.org/10.1007/s11307-015-0908-7openalex-snapshot
Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer
inferred← citeshttps://doi.org/10.1007/s12551-021-00919-1openalex-snapshot
Metamorphosis of prostate specific membrane antigen (PSMA) inhibitors
inferred← citeshttps://doi.org/10.1007/s13233-013-1050-5openalex-snapshot
Synthesis and biological evaluation of substrate-based imaging agents for the prostate-specific membrane antigen
inferred← citeshttps://doi.org/10.1016/j.bbrc.2009.10.017openalex-snapshot
A low molecular weight PSMA-based fluorescent imaging agent for cancer
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.09.057openalex-snapshot
A targeted low molecular weight near-infrared fluorescent probe for prostate cancer
inferred← citeshttps://doi.org/10.1016/j.bmcl.2011.09.115openalex-snapshot
Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.04.110openalex-snapshot
Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.11.015openalex-snapshot
Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles
inferred← citeshttps://doi.org/10.1016/j.bmcl.2023.129573openalex-snapshot
PSMA-targeted small-molecule drug-conjugates with valine-citrulline and phosphoramidate cleavable linkers
inferred← citeshttps://doi.org/10.1016/j.bmcl.2024.129657openalex-snapshot
PSMA-targeted SMART molecules outfitted with SN38
inferred← citeshttps://doi.org/10.1016/j.bmcl.2024.129712openalex-snapshot
A PSMA-targeted doxorubicin small-molecule drug conjugate
inferred← citeshttps://doi.org/10.1016/j.bmcl.2025.130213openalex-snapshot
A small-molecule pretargeting approach for PSMA-targeted conjugates
inferred← citeshttps://doi.org/10.1016/j.canlet.2010.04.003openalex-snapshot
Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2015.06.003openalex-snapshot
A high-affinity [18F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.urolonc.2023.08.019openalex-snapshot
Extracellular vesicle biomarkers for prostate cancer diagnosis: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.1c00435openalex-snapshot
Prostate-Specific Membrane Antigen-Targeted Turn-on Probe for Imaging Cargo Release in Prostate Cancer Cells
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c02767openalex-snapshot
Development of [ 99m Tc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01850openalex-snapshot
Structure–Activity Relationship of 18F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.8b00026openalex-snapshot
Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA–Paclitaxel Conjugate
inferred← citeshttps://doi.org/10.1021/bc3003919openalex-snapshot
Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1021/bc500362nopenalex-snapshot
Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer
inferred← citeshttps://doi.org/10.1021/bi801883vopenalex-snapshot
Pseudoirreversible Inhibition of Prostate-Specific Membrane Antigen by Phosphoramidate Peptidomimetics
inferred← citeshttps://doi.org/10.1021/mp4000844openalex-snapshot
A Multivalent Approach of Imaging Probe Design To Overcome an Endogenous Anion Binding Competition for Noninvasive Assessment of Prostate Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1021/mp900069dopenalex-snapshot
Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand
inferred← citeshttps://doi.org/10.1038/srep23314openalex-snapshot
In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe
inferred← citeshttps://doi.org/10.1039/9781849733151-00062openalex-snapshot
Glutamate Carboxypeptidase II as a Therapeutic Target
inferred← citeshttps://doi.org/10.1039/c6cs00908eopenalex-snapshot
Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy
inferred← citeshttps://doi.org/10.1039/d0bm01970dopenalex-snapshot
A targeted near-infrared nanoprobe for deep-tissue penetration and imaging of prostate cancer
inferred← citeshttps://doi.org/10.1039/d3bm00002hopenalex-snapshot
Intracellular regulation of zinc by metal–organic framework-mediated genome editing for prostate cancer therapy
inferred← citeshttps://doi.org/10.1080/14737140.2022.2081155openalex-snapshot
Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancer
inferred← citeshttps://doi.org/10.1080/14737159.2016.1243057openalex-snapshot
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer
inferred← citeshttps://doi.org/10.1080/23723556.2022.2136476openalex-snapshot
Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target
inferred← citeshttps://doi.org/10.1089/cbr.2019.3079openalex-snapshot
Comparison of Prostate-Specific Membrane Antigen Expression Levels in Human Salivary Glands to Non-Human Primates and Rodents
inferred← citeshttps://doi.org/10.1158/0008-5472.can-09-1682openalex-snapshot
Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-11-1357openalex-snapshot
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
inferred← citeshttps://doi.org/10.1200/jco.23.02310openalex-snapshot
Resolute Progress Down a Long and Winding Road Leads to the Promised Land of Prostate-Specific Membrane Antigen–Based Therapies for Prostate Cancer
inferred← citeshttps://doi.org/10.2116/analsci.34.273openalex-snapshot
In Vivo Molecular Imaging for Biomedical Analysis and Therapies
inferred← citeshttps://doi.org/10.2174/092986712799034888openalex-snapshot
Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
inferred← citeshttps://doi.org/10.2174/0929867329666220401105929openalex-snapshot
Selective Delivery of Clinically Approved Tubulin Binding Agents through Covalent Conjugation to an Active Targeting Moiety
inferred← citeshttps://doi.org/10.2174/1568026611313080008openalex-snapshot
PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.2174/1568026619666190201100739openalex-snapshot
Recent Advances in Prostate-Specific Membrane Antigen-Based Radiopharmaceuticals
inferred← citeshttps://doi.org/10.2217/imt.09.17openalex-snapshot
Targeting the Prostate-Specific Membrane Antigen for Prostate Cancer Therapy
inferred← citeshttps://doi.org/10.2967/jnumed.109.066589openalex-snapshot
Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer
inferred← citeshttps://doi.org/10.2967/jnumed.109.069492openalex-snapshot
Targeting Prostate Cancer Cells In Vivo Using a Rapidly Internalizing Novel Human Single-Chain Antibody Fragment
inferred← citeshttps://doi.org/10.2967/jnumed.112.116624openalex-snapshot
99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.3389/fonc.2024.1504514openalex-snapshot
Repurposing of PSMA-targeted diagnostic and therapeutic agents for the detection and treatment of giant cell tumors of bone
inferred← citeshttps://doi.org/10.3389/fonc.2025.1454392openalex-snapshot
Photodynamic therapy for the precise treatment of localized prostate cancer
inferred← citeshttps://doi.org/10.3390/ijms23137160openalex-snapshot
Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists
inferred← citeshttps://doi.org/10.3390/molecules22040523openalex-snapshot
Metal-Based PSMA Radioligands
inferred← citeshttps://doi.org/10.3390/molecules25071743openalex-snapshot
Targeted Radionuclide Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives
inferred← citeshttps://doi.org/10.3892/ijo.2012.1649openalex-snapshot
Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
inferred← citeshttps://doi.org/10.3892/ijo.2014.2256openalex-snapshot
Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells
inferred← citeshttps://doi.org/10.3892/ijo.2017.4095openalex-snapshot
Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo
inferred← citeshttps://doi.org/10.3892/ijo_00000553openalex-snapshot
Targeted photodynamic therapy for prostate cancer: Inducing apoptosis via activation of the caspase-8/-3 cascade pathway
inferred← citeshttps://doi.org/10.4236/jct.2012.34043openalex-snapshot
Role of Prostate Specific Antigen (PSA) in Pathogenesis of Prostate Cancer
inferred← citeshttps://doi.org/10.4274/uob.galenos.2019.1144openalex-snapshot
Prostate-specific Membrane Antigen-Based Nanomedicine Applications in the Diagnosis and Treatment of Prostate Cancer
inferred← citeshttps://doi.org/10.7150/thno.18719openalex-snapshot
177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice
inferred← citeshttps://doi.org/10.7507/1001-5515.201911073openalex-snapshot
[Recent progress of positron radionuclide labeled small molecule inhibitors of prostate specific membrane antigen for PET/CT imaging of prostate cancer].
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.